The ethics of CYP2D6 testing for patients considering tamoxifen

por Hartman, Anne-Renee, Helft, Paul
Publicado em 2007

Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells

por Alli, Elizabeth, Sharma, Vandana B, Hartman, Anne-Renee, Lin, Patrick S, McPherson, Lisa, Ford, James M
Publicado em 2011

Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal...

por Kurian, Allison W., Hartman, Anne‐Renee, Mills, Meredith A., Ford, James M., Daniel, Bruce L., Plevritis, Sylvia K.
Publicado no Health Expect (2005)

Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort

por Ring, Kari L., Bruegl, Amanda S., Allen, Brian A., Elkin, Eric P., Singh, Nanda, Hartman, Anne-Renee, Daniels, Molly S., Broaddus, Russell R.
Publicado no Mod Pathol (2016)

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer

por Tung, Nadine, Lin, Nancy U., Kidd, John, Allen, Brian A., Singh, Nanda, Wenstrup, Richard J., Hartman, Anne-Renee, Winer, Eric P., Garber, Judy E.
Publicado no J Clin Oncol (2016)

Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients with Suspected Lynch Syndrome

por Yurgelun, Matthew B., Allen, Brian, Kaldate, Rajesh R., Bowles, Karla R., Judkins, Thaddeus, Kaushik, Praveen, Roa, Benjamin B., Wenstrup, Richard J., Hartman, Anne-Renee, Syngal, Sapna
Publicado no Gastroenterology (2015)

PREVALENCE OF GERMLINE MUTATIONS IN CANCER GENES AMONG PANCREATIC CANCER PATIENTS WITH POSITIVE FAMILY HISTORY

por Chaffee, Kari G., Oberg, Ann L., McWilliams, Robert R., Majithia, Neil, Allen, Brian A., Kidd, John, Singh, Nanda, Hartman, Anne-Renee, Wenstrup, Richard J., Petersen, Gloria M.
Publicado no Genet Med (2017)

Tumor BRCA1 Reversion Mutation Arising During Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance

por Afghahi, Anosheh, Timms, Kirsten M., Vinayak, Shaveta, Jensen, Kristin C., Kurian, Allison W., Carlson, Robert W., Chang, Pei-Jen, Schackmann, Elizabeth, Hartman, Anne-Renee, Ford, James M., Telli, Melinda L.
Publicado no Clin Cancer Res (2017)

Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma

por Eguchi, Takashi, Kadota, Kyuichi, Chaft, Jamie, Evans, Brent, Kidd, John, Tan, Kay See, Dycoco, Joe, Kolquist, Kathryn, Davis, Thaylon, Hamilton, Stephanie A., Yager, Kraig, Jones, Joshua T., Travis, William D., Jones, David R., Hartman, Anne-Renee, Adusumilli, Prasad S.
Publicado no Oncotarget (2016)

Validation of a Molecular and Pathological Model for Five-Year Mortality Risk in Patients with Early Stage Lung Adenocarcinoma

por Bueno, Raphael, Hughes, Elisha, Wagner, Susanne, Gutin, Alexander S., Lanchbury, Jerry S., Zheng, Yifan, Archer, Michael A., Gustafson, Corinne, Jones, Joshua T., Rushton, Kristen, Saam, Jennifer, Kim, Edward, Barberis, Massimo, Wistuba, Ignacio, Wenstrup, Richard J., Wallace, William A., Hartman, Anne-Renee, Harrison, David J.
Publicado no J Thorac Oncol (2015)

Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma

por Clarke, Loren E., Warf, M.B., Flake, Darl D., Hartman, Anne‐Renee, Tahan, Steven, Shea, Christopher R., Gerami, Pedram, Messina, Jane, Florell, Scott R., Wenstrup, Richard J., Rushton, Kristen, Roundy, Kirstin M., Rock, Colleen, Roa, Benjamin, Kolquist, Kathryn A., Gutin, Alexander, Billings, Steven, Leachman, Sancy
Publicado no J Cutan Pathol (2015)

Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer

por Yurgelun, Matthew B., Kulke, Matthew H., Fuchs, Charles S., Allen, Brian A., Uno, Hajime, Hornick, Jason L., Ukaegbu, Chinedu I., Brais, Lauren K., McNamara, Philip G., Mayer, Robert J., Schrag, Deborah, Meyerhardt, Jeffrey A., Ng, Kimmie, Kidd, John, Singh, Nanda, Hartman, Anne-Renee, Wenstrup, Richard J., Syngal, Sapna
Publicado no J Clin Oncol (2017)

BRCA1, BRCA2, PALB2, and CDKN2A Mutations in Familial Pancreatic Cancer (FPC): A PACGENE Study

por Zhen, David B., Rabe, Kari G., Gallinger, Steven, Syngal, Sapna, Schwartz, Ann G., Goggins, Michael G., Hruban, Ralph H., Cote, Michele L., McWilliams, Robert R., Roberts, Nicholas J., Cannon-Albright, Lisa A., Li, Donghui, Moyes, Kelsey, Wenstrup, Richard J., Hartman, Anne-Renee, Seminara, Daniela, Klein, Alison P., Petersen, Gloria M.
Publicado no Genet Med (2014)

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer

por Isakoff, Steven J., Mayer, Erica L., He, Lei, Traina, Tiffany A., Carey, Lisa A., Krag, Karen J., Rugo, Hope S., Liu, Minetta C., Stearns, Vered, Come, Steven E., Timms, Kirsten M., Hartman, Anne-Renee, Borger, Darrel R., Finkelstein, Dianne M., Garber, Judy E., Ryan, Paula D., Winer, Eric P., Goss, Paul E., Ellisen, Leif W.
Publicado no J Clin Oncol (2015)

Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation–Associated Breast Cancer With Assessment of a Tumor-Based M...

por Telli, Melinda L., Jensen, Kristin C., Vinayak, Shaveta, Kurian, Allison W., Lipson, Jafi A., Flaherty, Patrick J., Timms, Kirsten, Abkevich, Victor, Schackmann, Elizabeth A., Wapnir, Irene L., Carlson, Robert W., Chang, Pei-Jen, Sparano, Joseph A., Head, Bobbie, Goldstein, Lori J., Haley, Barbara, Dakhil, Shaker R., Reid, Julia E., Hartman, Anne-Renee, Manola, Judith, Ford, James M.
Publicado no J Clin Oncol (2015)

Patient communication of cancer genetic test results in a diverse population

por Ricker, Charité N, Koff, Rachel B, Qu, Chenxu, Culver, Julie, Sturgeon, Duveen, Kingham, Kerry E, Lowstuter, Katrina, Chun, Nicolette M, Rowe-Teeter, Courtney, Lebensohn, Alexandra, Levonian, Peter, Partynski, Katlyn, Lara-Otero, Karlena, Hong, Christine, Petrovchich, Iva M, Mills, Meredith A, Hartman, Anne-Renee, Allen, Brian, Ladabaum, Uri, McDonnell, Kevin, Ford, James M, Gruber, Stephen B, Kurian, Allison W, Idos, Gregory E
Publicado no Transl Behav Med (2018)

Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancers

por Telli, Melinda L., Timms, Kirsten M., Reid, Julia, Hennessy, Bryan, Mills, Gordon B., Jensen, Kristin C., Szallasi, Zoltan, Barry, William T., Winer, Eric P., Tung, Nadine M., Isakoff, Steven J., Ryan, Paula D., Greene-Colozzi, April, Gutin, Alexander, Sangale, Zaina, Iliev, Diana, Neff, Chris, Abkevich, Victor, Jones, Joshua T., Lanchbury, Jerry S., Hartman, Anne-Renee, Garber, Judy E., Ford, James M., Silver, Daniel P., Richardson, Andrea L.
Publicado no Clin Cancer Res (2016)

Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk

por Idos, Gregory E., Kurian, Allison W., Ricker, Charité, Sturgeon, Duveen, Culver, Julie O., Kingham, Kerry E., Koff, Rachel, Chun, Nicolette M., Rowe-Teeter, Courtney, Lebensohn, Alexandra P., Levonian, Peter, Lowstuter, Katrina, Partynski, Katlyn, Hong, Christine, Mills, Meredith A., Petrovchich, Iva, Ma, Cindy S., Hartman, Anne-Renee, Allen, Brian, Wenstrup, Richard J., Lancaster, Johnathan M., Brown, Krystal, Kidd, John, Evans, Brent, Mukherjee, Bhramar, McDonnell, Kevin J., Ladabaum, Uri, Ford, James M., Gruber, Stephen B.
Publicado no JCO Precis Oncol (2019)